Silence Therapeutics plc Increase Decrease In Operating Lease Liability
Silence Therapeutics plc (SLN) reported Increase Decrease In Operating Lease Liability of -$48.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Silence Therapeutics plc increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$24.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$24.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$22.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$20.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for fiscal 2025 was -$168.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for fiscal 2024 was -$165.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for fiscal 2023 was -$175.00K.
- Silence Therapeutics plc increase decrease in operating lease liability for fiscal 2022 was -$235.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$48.00K 10-Q · filed 2026-08-10 | -$70.00K derived: sum of 3 quarters · filed 2026-08-10 | -$90.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$24.00K 10-Q · filed 2026-05-07 | -$46.00K derived: sum of 2 quarters · filed 2026-05-07 | -$66.00K derived: sum of 3 quarters · filed 2026-05-07 | -$133.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$42.00K derived: sum of 2 quarters · filed 2026-03-05 | -$109.00K derived: sum of 3 quarters · filed 2026-08-10 | -$168.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$87.00K derived: sum of 2 quarters · filed 2026-08-10 | -$146.00K 10-Q · filed 2025-11-06 | -$170.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$126.00K 10-Q · filed 2026-08-10 | -$150.00K derived: sum of 3 quarters · filed 2026-08-10 | -$200.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$59.00K 10-Q · filed 2026-05-07 | -$83.00K derived: sum of 2 quarters · filed 2026-05-07 | -$133.00K derived: sum of 3 quarters · filed 2026-05-07 | -$240.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$74.00K derived: sum of 2 quarters · filed 2026-03-05 | -$181.00K derived: sum of 3 quarters · filed 2026-03-05 | -$165.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$157.00K derived: sum of 2 quarters · filed 2025-11-06 | -$141.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$91.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $16.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$175.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | -$235.00K 10-K · filed 2025-02-27 |